[go: up one dir, main page]

AU2002218269A1 - Proteins and dna sequences underlying these proteins used for treating inflammations - Google Patents

Proteins and dna sequences underlying these proteins used for treating inflammations

Info

Publication number
AU2002218269A1
AU2002218269A1 AU2002218269A AU1826902A AU2002218269A1 AU 2002218269 A1 AU2002218269 A1 AU 2002218269A1 AU 2002218269 A AU2002218269 A AU 2002218269A AU 1826902 A AU1826902 A AU 1826902A AU 2002218269 A1 AU2002218269 A1 AU 2002218269A1
Authority
AU
Australia
Prior art keywords
proteins
dna sequences
treating inflammations
sequences underlying
underlying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218269A
Inventor
Fabio Martinon
Jurg Tschopp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topotarget Switzerland SA
Original Assignee
Apotech Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10059595A external-priority patent/DE10059595A1/en
Application filed by Apotech Research and Development Ltd filed Critical Apotech Research and Development Ltd
Publication of AU2002218269A1 publication Critical patent/AU2002218269A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002218269A 2000-11-15 2001-10-30 Proteins and dna sequences underlying these proteins used for treating inflammations Abandoned AU2002218269A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10056687 2000-11-15
DE10056687.1 2000-11-15
DE10059595.2 2000-11-30
DE10059595A DE10059595A1 (en) 2000-11-15 2000-11-30 Proteins and the DNA sequences underlying the proteins with function in inflammatory events
PCT/EP2001/012545 WO2002040668A2 (en) 2000-11-15 2001-10-30 Proteins and dna sequences underlying these proteins used for treating inflammations

Publications (1)

Publication Number Publication Date
AU2002218269A1 true AU2002218269A1 (en) 2002-05-27

Family

ID=26007674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218269A Abandoned AU2002218269A1 (en) 2000-11-15 2001-10-30 Proteins and dna sequences underlying these proteins used for treating inflammations

Country Status (4)

Country Link
US (1) US20040053292A1 (en)
EP (1) EP1349933A2 (en)
AU (1) AU2002218269A1 (en)
WO (1) WO2002040668A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243234A1 (en) * 2000-11-15 2002-06-24 Incyte Genomics, Inc. Embryogenesis associated proteins
US6949363B2 (en) 2000-12-22 2005-09-27 Brilstol-Myers Squibb Polynucleotides encoding novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
ES2265389T3 (en) 2000-12-22 2007-02-16 Bristol-Myers Squibb Company HUMAN PROTEIN CONTAINING REPETITIONS RICH IN LEUCINE EXPRESSED PREDOMINANTLY IN THE INTESTINE DELGADO, HLRRSI1.
WO2002061049A2 (en) * 2001-01-31 2002-08-08 Millennium Pharmaceuticals, Inc. Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
US7041643B2 (en) 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
DE10139874A1 (en) 2001-08-10 2003-04-30 Schering Ag Human mater proteins
US20040002593A1 (en) * 2002-04-04 2004-01-01 Reed John C. PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use
US20030224438A1 (en) * 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
CA2604135A1 (en) * 2005-04-07 2006-10-19 University Of South Florida Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
WO2008066483A1 (en) * 2006-11-27 2008-06-05 Mohammad Alimohammadi Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders
US8685400B2 (en) * 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
GB0724735D0 (en) * 2007-12-19 2008-01-30 Psynova Neurotech Ltd Methods and biomarkers for diagnosing and monitoring psychotic disorders
GB0818660D0 (en) * 2008-10-10 2008-11-19 Cambridge Entpr Ltd Biomarkers
CN106011233A (en) * 2010-08-13 2016-10-12 莫尔豪斯医学院 Biomarkers for stroke
EP2656081B1 (en) 2010-12-20 2017-09-06 Cambridge Enterprise Ltd. Method and biomarkers for differentially diagnosing psychotic disorders
GB201021502D0 (en) 2010-12-20 2011-02-02 Cambridge Entpr Ltd Biomarkers
GB201404189D0 (en) 2014-03-10 2014-04-23 Cambridge Entpr Ltd Novel biomarkers
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813839A1 (en) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy
CA2373191A1 (en) * 1999-05-14 2000-11-23 Incyte Genomics, Inc. Full-length molecules expressed in human tissues

Also Published As

Publication number Publication date
US20040053292A1 (en) 2004-03-18
EP1349933A2 (en) 2003-10-08
WO2002040668A3 (en) 2003-07-03
WO2002040668A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU2002218269A1 (en) Proteins and dna sequences underlying these proteins used for treating inflammations
AU2001236638A1 (en) Evi27 gene sequences and protein encoded thereby
AU2002352554A1 (en) G protein coupled receptors and dna sequences thereof
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU5245900A (en) Novel protein and dna thereof
AU2002220215A1 (en) Novel proteins and nucleic acids encoding same
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001278655A1 (en) Novel nucleic acid and amino acid sequences
WO2002094870A8 (en) Proteins and nucleic acids encoding same
AU2001239756A1 (en) Novel proteins and nucleic acids encoding same
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU2001266813A1 (en) Human proteins and nucleic acids encoding same
AU6550598A (en) Antithrombin protein and dna sequences
AU2002227445A1 (en) Proteins and nucleic acids encoding same
AU2225401A (en) Novel protein and dna thereof
AU1690200A (en) Novel protein and dna thereof
AU2001297707A1 (en) Motor proteins and methods for their use
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2001274563A1 (en) Novel polypeptide and its dna
AU5447999A (en) Novel protein and dna thereof
AU2392501A (en) Protein binding parathyroid hormone nucleotide sequences and uses thereof